Skip to content

Automatic Administration of Oxygen During Respiratory Distress

Automation of the Oxygen's Administration in Spontaneous Ventilation (FreeO2) During the Hypoxemic Acute Respiratory Distress

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02027181
Acronym
FreeO2-Hypox
Enrollment
190
Registered
2014-01-06
Start date
2011-08-31
Completion date
2014-10-31
Last updated
2014-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Distress Syndrome, Hypoxemia

Brief summary

Aim: The purpose of this study is to evaluate the use feasibility of FreeO2 so as to deliver automatically oxygen in the emergency department in a patient population admitted for acute respiratory failure. Hypothesis: The principal hypothesis is that FreeO2 is possible and well-accepted by nurses and medical personnel and there are advantages to use this system. In comparison with the common oxygen delivery (the rotameter), the hypothesis is that FreeO2 system will make for a better control of the oxygen saturation in function of designed target, reducing the desaturation time and hyperoxia. We think that oxygen weaning will be faster than classical way if it is automated. In addition, FreeO2 could reduce the number of intervention by nurse personnel.

Interventions

DEVICEDevice FreeO2 v2.0

* Automatic adjustment of oxygen through the Free O2 device. * FreeO2 device in mode medical data collecting(SpO2,EtCO2...).

Sponsors

Ministry of Health, France
CollaboratorOTHER_GOV
University Hospital, Brest
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Admission to the emergency for respiratory disease (or cardiac - acute pulmonary edema)justifying an oxygen administration to over 3 L / min to maintain a SpO2 ≥ 92%. * Inclusion within a time less than two hours after the start of the oxygen at the emergency. * Patient consent,or a close.

Exclusion criteria

* Necessity of an oxygen flow exceeds 15 L / min to maintain a SpO2 higher than 92%. * Criteria of gravity justifying immediately a different technique of ventilatory support: * Disturbance of consciousness with a Glasgow Coma Score ≤ 12 * Serious ventricular rhythm disorders * Hemodynamic instability (SBP \<80mmHg or recourse to vasopressors) * Cardiac or respiratory arrest * pH \< 7.35 and PaCO2 \> 55 mm Hg * Necessity of a urgent surgery, or coronary revascularization * Age \<18 years * Pregnant women, lactating * Patient not relevant * Unavailability of the prototype FreeO2

Design outcomes

Primary

MeasureTime frameDescription
Percentage of time spent in the target zone of oxygen saturation in the acute phase of treatment3 hours or 1 hour after after cessation of oxygenationThe target zone of oxygen saturation is : SpO2 = 92-96% The acute phase of treatment is defined by the 3 first hours of treatment by oxygenation and/or until one hour after the end of this last.

Secondary

MeasureTime frame
nursing workload assessed by the number of manual Oxygen flow adjustments and airway management procedures3 days max
Time spent in a area of severe desaturation (SpO2 <88%) and a hyperoxia area (SpO2> 98%).3 hours or 1 hour after after cessation of oxygenation
Maintaining EtCO2 in a selected area3 hours or 1 hour after after cessation of oxygenation
Oxygen consumption measured at the end of administration3 hours or 1 hour after after cessation of oxygenation
Duration of administration during hospitalization28 days max
Number of complications related to the administration of oxygen28 days max
Frequency of use of invasive or noninvasive ventilation during hospitalization.28 days max

Countries

Canada, France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026